# Sulfasalazine

## Salazine 500mg

| 藥物代碼           | OSAL5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Inflammatory bowel disease including Crohn's disease, ulcerative colitis, Active RA, ankylosing spondylitis.                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | Nausea, anorexia, raised temp; erythema & pruritus; headache. Rarely, hematological, GI, CNS, renal, dermatological reactions.Dermatologic: Pruritus (3% to 4% ), Rash (3% to 13% )Gastrointestinal: Abdominal pain (8% ), Indigestion (13% to 33% ), Loss of appetite (33% ), Nausea (19% to 33% ), Stomatitis (4% ), Vomiting (8% to 33% )Neurologic: Dizziness (4% ), Headache (9% to 33% )Renal: Discolored urineReproductive: Oligozoospermia, Reversible (33% )Other: Fever (3% to 5% ) |
| 禁忌               | Hypersensitivity to sulfonamides & salicylates. Acute intermittent porphyria. Infant < 2 years.                                                                                                                                                                                                                                                                                                                                                                                               |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Inflammatory bowel disease including Crohn's disease, ulcerative colitis Adult Mild to moderate attacks: 2 tab tid or qid. Severe attacks: 2-4 tab tid or qid. Children 40-60 mg/kg body weight/day in 3-6 doses. Maintenance: Adult 2 tab bid or tid. Children 20-30 mg/kg body weight/day in 3-6 divided doses. Active RA, ankylosing spondylitis 2 tab bid or tid. child: under 2 years, not recommended.                                                                                  |
| 肝功能異常         | 無需調整劑量  腎及肝功能不全者應小心使用,且應定期檢查尿液及肝功能                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 孕期用藥建議       | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

